Insulin sensitivity in chronic pancreatitis and features of insulin resistance syndrome

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 7-8, 2010, Pages 255-263

  Niebisz Cieślak, Agnieszka B ^a   Karnafel, Waldemar ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chronic pancreatitis; Insulin sensitivity; Pancreatic diabetes

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77955903363     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.939     Document Type: Article

References (38)

1. Romatowski JA, Stasiewicz J. Chronic pancreatitis: disturbances of endocrine function of pancreas. Medical Science Review. 2004; 3: 39-42.
2. Chang TM, Chey WY. Neurohormonal control of exocrine pancreas. Curr Opinion Gastroenterol. 2001; 17: 416-425.
3. Domschke S, Bloom SR, Adrian TE, et al. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). Hepatogastroenterology. 1988; 35: 229-237.
4. Szczeklik A, ed. [Internal diseases]. Vol 1. Kraków, Poland: Medycyna Praktyczna; 2005: 866-872.
5. Mohan V, Ramachandran A, Kumar GV, et al. Insulin resistance in Fibrocalculous (tropical) pancreatic diabetes. Horm Metab Res. 1988; 20: 746-748. (Pubitemid 19015037)
6. Cavallini G, Vaona B, Bovo P, et al. Diabetes in chronic alcoholic pancreatitis: role of residual beta cell function and insulin resistance. Dig Dis Sci. 1993; 38: 497-501.
7. Seymour NE, Turk JB, Laster MK, et al. In vitro hepatic insulin resistance in chronic pancreatitis in the rat. J Surg Res. 1989; 46: 450-456.
8. Yki-Järvinen H, Kiviluoto T, Taskinen MR. Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism. 1986; 35: 718-727. (Pubitemid 16040623)
9. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). National Institute of Health. NIH Publication; 2002, 02-5215.
10. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org. Accessed April 15, 2005.
11. Pupek-Musialik D, Bryl W. [Metabolic syndrome - new guidelines, new challenges]. Przewodnik Lekarza. 2006; 6: 94-97. Polish.
12. Michael B, Elasy TA. [Clinical application of the definition of metabolic syndrome: what is the source of the doubts?] Diabetologia po Dyplomie. 2006; 3: 27-34. Polish.
13. Poirier P, Eckel RH. Obesity and cardiovascular disease. Curr Atheroscler Rep. 2002; 4: 448-453.
14. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67: 968-977.
15. [Clinical care practice for patients with diabetes 2008 - Guidelines of Polish Diabetes Association]. 2008; 9 (Suppl A): A1-A3. Polish.
16. Blachowicz J, Wójcicki J, Ładyżyński P, Krzymień J. [Measurement of tissue glucose utilization in human body]. Prace Instytutu Biocybernetyki i Inżynierii Biomedycznej. 1996; 48: 31-47. Polish.
17. Blachowicz J, Wójcicki J, Ładyżyński P, Krzymień J. [Measurement of tissue glucose utilization in human body]. Prace Instytutu Biocybernetyki i Inżynierii Biomedycznej. 1996; 48: 60-61. Polish.
18. Mohammed el A, Mohamed M, Denis L, Rekia B. Prevalence of parameter indicators of obesity and its relationship with metabolic syndrome in urban Moroccan women. Am J Hum Biol. 2008; 20: 484-486.
19. Reeder BA, Angel A, Ledoux M, et al. Obesity and its relation to cardio vascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992; 146: 2009-2019.
20. Cox BD, Whichelow MJ, Prevost AT. The development of cardiovascular disease in relation to anthropometric indices and hypertension in British adults. Int J Obes Relat Metab Disord. 1998; 22: 966-973.
21. Garnett SP, Baur LA, Cowell CT. Waist-to-height ratio: a simple option for determining excess central adiposity in young people. Int J Obes (Lond). 2008; 32: 1028-1030.
22. Rabkin SW, Chen Y, Leiter L, et al. Risk factor correlates of body mass index. Canadian Health Surveys Research Group. CMAJ. 1997; 157: S26-31.
23. McLaughlin T, Allison G, Abbasi F, et al. Prevalence of insulin resistance and associated disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 2004; 53: 495-499.
24. Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference correlate to the same degree with insulin mediated glucose uptake. Metabolism. 2005; 54: 1323-1328.
25. Stanisz A. [A course in statistics using STATISTICA PL software and clinical medicine- based examples]. Vol 1. Kraków, Poland: StatSoft; 2006; 115-144, 221-234, 289-300. Polish.
26. Al-Lawati JA, Jousilahti P. Body mass index, waist circumference and waist-to-hip ratio cut-off points for categorization of obesity among Omani Arabs. Public Health Nutr. 2008; 11: 102-108.
27. Nyamdori R, Qiao Q, Soderberg S, et al. Comparison of body mass index with waist circumference, waist-to-hip ratio and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius. J. Hypertens. 2008; 26: 866-870.
28. Dalton M, Cameron AJ, Zimmet PZ, et al. Waist circumference, waist-hip ratio and body mass index and their correlation with cardiovascular disease risk factors in Australian adults. J Intern Med. 2003; 254: 555-563.
29. Edwards LA, Bugaresti JM, Buchhortz AC. Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences. Am J Clin Nutr. 2008; 87: 600-607.
30. Narksawat K, Podang J, Punyarathabundu, et al. Waist circumference, body mass index and health risk factors among middle aged Thais. Asia Pac J Public Health. 2007; 19: 10-15.
31. Parikh RM, Joshi SR, Menon PS, Shah NS. Index of central obesity - a novel parameter. Med Hypotheses. 2007; 68: 1272-1275.
32. Lemieux I, Pascot A, Coilard C, et al. Hipertriglycerydemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia, hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000; 102: 179-184.
33. Rashid S, Watanabe T, Sakaue T, et al. Mechanisms of HDL lowering in insulin resistance, hypertrigliyeridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity. Clin Biochem. 2003; 36: 421-429.
34. Fontbonne A, Eschwège EE, Cambien F, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 1989; 32: 300-304.
35. Yki-Järvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia. 1998; 41: 369-379.
36. Sechi LA. Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens. 1999; 17: 1229-1237.
37. Scherer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation. 1997; 96: 4104-4113.
38. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia. 1992; 35: 873-879.